Bioelectronic Medicine

Tivic Health focuses on a fast-growing area of healthcare called Bioelectronic Medicine. Our bodies use electrical signals in nerves to communicate, and bioelectronic devices help by gently influencing these signals to reduce symptoms and address the root causes of certain health conditions.

A HEALTHIER & SAFER TREATMENT

Our Revolutionary Approach

Tivic Health is at the fore of bioelectronic medicine. While this field has relied on implanted devices in the past, Tivic Health is focused on non-invasive approaches, which can be developed with less risk and are more accessible to the people who need them.

KEY elements of the clearup design include:

Approved by the FDA and held to rigorous quality standards for safety and efficacy.
Proprietary algorithms detect optimal treatment zones.
The first bioelectronic home-use device clinically proven and specifically designed for sinus relief.
How it works

Clinical Research | ClearUP® Sinus Pain Relief

Our flagship product, ClearUP®, is a groundbreaking, patented handheld device that uses gentle electrical stimulation to target symptoms of sinus and nasal inflammation. ClearUP is designed to relieve congestion, sinus pain, sinus pressure, and sinus headaches caused by allergies, chronic sinus conditions, colds, and the flu. For optimal results, ClearUP works most effectively as part of a regular routine. Continued use maximizes comfort and relief from sinus discomfort. 

Clinical Results

Rapid Relief Acheived

Congestion Relief
88%

of patients experience significant congestion reduction with ClearUP

Prefer ClearUp
82%

of patients prefer ClearUP to other allergy treatments

Relief After 1st Use
74%

of patients experience pain relief on the first use

Avoid Medications
58%

of sinus patients try to avoid medication—ClearUp is 100% drug-free

Sinus pain relief illustration

Fast-acting relief within 10 minutes

First clinical trial

First clinical trial results

Long-term symptom relief with regular use

Second clinical trial

Subjects used ClearUP at home for 4 weeks and experienced continuous improvement with extended use. 

Second clinical trial results

THE PHYSICIAN'S VIEW

Why Physicians Love ClearUP

Subinoy Das, MD

CEO, US Institute for Advanced Sinus Care & Research

Alan Goldsobel, MD 

Board Certified Allergist and Adjunct Clinical Professor, Stanford University Medical School

ClearUP Mechanisms of Action: Two Principal Pathways

1. Vasoconstriction

The blood vessels that supply the sinus and nasal mucosa are surrounded by sympathetic nerve fibers.
Electrical stimulation of sympathetic nerve fibers has been shown to promote release of norepinephrine. 1-3
Norepinephrine facilitates smooth muscle contraction around the blood vessels, leading to vasoconstriction. 4
Vasoconstriction of arterioles and venous vessels, in the context of sinonasal inflammation, results in smaller vessel diameter, relieving pressure on the nerves and reducing resistance to air flow.
Over time, repeated vasoconstriction can reduce edema and extravasation of inflammatory immune cells, contributing to reduced symptom severity.

2. Trigeminal Nerve Stimulation

The trigeminal nerve — the ophthalmic nerve (V1) and maxillary nerve (V2) — is responsible for relaying sensory information to the brain.
Electrical microcurrent delivered in the periorbital regions stimulates subcutaneous fibers of these branches.
Neuromodulation of the trigeminal nerve pathway may alleviate sensations of pain and pressure.

LEARN MORE ABOUT EMERGING RESEARCH
Mechanism of Action Diagram

Resources

  1. Mandel, Yossi, et al. “Vasoconstriction by electrical stimulation: new approach to control of non-compressible hemorrhage.” Scientific Reports 3 (2013)
  2. Franco, O.S., et al. “Effects of different frequencies of transcutaneous electrical nerve stimulation on venous vascular reactivity.” Brazilian Journal of Medical and Biological Research 47.5 (2014): 411-418.
  3. Malm, L. “Stimulation of sympathetic nerve fibres to the nose in cats.” Acta otolaryngologica 75.2-6 (1973); 519-526.
  4. Fischer, Laurent, et al. “Adrenergic and non-adrenergic vasoconstrictor mechanisms in the human nasal mucosa.” Rhinology 31.1 (1993): 11-15.